BeiGene, Ltd. (BGNE)
Company Info
ISIN | US07725L1026 |
---|---|
CUSIP | 07725L102 |
Sector | Healthcare |
Industry | Biotechnology |
Highlights
Market Cap | $16.82B |
---|---|
EPS | -$8.45 |
Revenue (TTM) | $2.46B |
Gross Profit (TTM) | -$511.06M |
EBITDA (TTM) | -$1.12B |
Year Range | $132.95 - $272.49 |
Target Price | $275.27 |
Short % | 5.88% |
Short Ratio | 6.13 |
Share Price Chart
Loading data...
Compare to other instruments
Popular comparisons: BGNE vs. COST, BGNE vs. VOO
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in BeiGene, Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
BeiGene, Ltd. had a return of -14.02% year-to-date (YTD) and -29.50% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -14.02% | 10.04% |
1 month | -3.23% | 3.53% |
6 months | -19.30% | 22.79% |
1 year | -29.50% | 32.16% |
5 years (annualized) | 3.28% | 13.15% |
10 years (annualized) | N/A | 10.96% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -17.81% | 11.75% | ||||||||||
2023 | -3.11% | -13.34% | 3.56% | 0.35% | -3.52% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for BeiGene, Ltd. (BGNE) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
BeiGene, Ltd. | -0.62 | ||||
S&P 500 | 2.76 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the BeiGene, Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the BeiGene, Ltd. was 69.96%, occurring on May 11, 2022. The portfolio has not yet recovered.
The current BeiGene, Ltd. drawdown is 61.53%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-69.96% | Sep 20, 2021 | 163 | May 11, 2022 | — | — | — |
-50.63% | Jun 11, 2018 | 99 | Oct 29, 2018 | 428 | Jul 14, 2020 | 527 |
-34.68% | Feb 17, 2021 | 130 | Aug 20, 2021 | 18 | Sep 16, 2021 | 148 |
-30.62% | Oct 11, 2017 | 25 | Nov 14, 2017 | 43 | Jan 18, 2018 | 68 |
-30.1% | Oct 19, 2020 | 33 | Dec 3, 2020 | 28 | Jan 14, 2021 | 61 |
Volatility
Volatility Chart
The current BeiGene, Ltd. volatility is 15.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |